We are live on ! Find out more
EDIT icon

Editas Medicine

194 hedge funds and large institutions have $149M invested in Editas Medicine in 2025 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 47 increasing their positions, 57 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

492% more call options, than puts

Call options by funds: $4.92M | Put options by funds: $830K

64% more capital invested

Capital invested by funds: $90.9M → $149M (+$58.4M)

4% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 23

0% more funds holding

Funds holding: 194194 (0)

1.47% less ownership

Funds ownership: 49.34%47.87% (-1.5%)

18% less repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 57

Holders
194
Holders Change
Holders Change %
0%
% of All Funds
2.55%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
24
Increased
47
Reduced
57
Closed
23
Calls
$4.92M
Puts
$830K
Net Calls
+$4.09M
Net Calls Change
+$2.85M
Name Holding Trade Value Shares
Change
Change in
Stake
AWM
101
Aries Wealth Management
Maine
$43.4K -$2.79K -1,000 -7%
Neuberger Berman Group
102
Neuberger Berman Group
New York
$41.6K -$4.77K -1,710 -12%
Prudential Financial
103
Prudential Financial
New Jersey
$39.8K -$4.13K -1,480 -11%
FPAS
104
Focus Partners Advisor Solutions
Missouri
$36.3K -$10K -3,597 -24%
GWM
105
Gibbs Wealth Management
Georgia
$35.8K
Victory Capital Management
106
Victory Capital Management
Texas
$35.6K +$28.6K +10,258 New
KCP
107
Kera Capital Partners
California
$35K
PD
108
Point72 (DIFC)
United Arab Emirates
$34.3K +$27.6K +9,878 New
BBA
109
Baader Bank Aktiengesellschaft
Germany
$31.2K +$40.6K +14,545 New
Citigroup
110
Citigroup
New York
$29K -$144K -51,526 -86%
AIP
111
Ameritas Investment Partners
Nebraska
$28.6K
Legal & General Group
112
Legal & General Group
United Kingdom
$27K
CIBC Private Wealth Group
113
CIBC Private Wealth Group
Georgia
$25.3K
AAP
114
Arax Advisory Partners
Colorado
$22.7K +$17.8K +6,379 +4,253%
KOC
115
Koss-Olinger Consulting
Florida
$22K
SCM
116
Sterling Capital Management
North Carolina
$20.2K +$9.72K +3,482 +149%
FDCDDQ
117
Federation des caisses Desjardins du Quebec
Quebec, Canada
$19.1K
California State Teachers Retirement System (CalSTRS)
118
California State Teachers Retirement System (CalSTRS)
California
$18.2K +$14.7K +5,255 New
New York State Common Retirement Fund
119
New York State Common Retirement Fund
New York
$15.2K
AWM
120
Activest Wealth Management
Florida
$13.9K
PE
121
Point72 Europe
United Kingdom
$13.3K +$10.7K +3,833 New
TRCT
122
Tower Research Capital (TRC)
New York
$12.9K -$34.1K -12,207 -77%
Mirae Asset Global Investments
123
Mirae Asset Global Investments
South Korea
$12.1K +$675 +242 +7%
SS
124
SBI Securities
Japan
$10.6K -$1.14K -407 -12%
AB
125
Amalgamated Bank
New York
$10K

EDIT Hedge Fund Activity: Q3 2025 in Review

194 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q3 2025, worth a combined $149M — up 64% from $90.9M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new EDIT positions and 23 closed out — a net gain of 1 holder — while 47 added to existing stakes and 57 trimmed.

The largest buyer was BlackRock, adding an estimated $3.35M. The largest seller was Millennium Management, cutting an estimated $4.3M.

  • 194 institutional investors held Editas Medicine (EDIT) as of Q3 2025, unchanged from Q2 2025.
  • Funds reported $149M of Editas Medicine stock for Q3 2025, up 64% quarter-over-quarter.
  • 24 funds opened new Editas Medicine positions in Q3 2025 and 23 closed out, a net change of +1 holder.
  • The largest Editas Medicine buyer in Q3 2025 was BlackRock, an estimated $3.35M added.
  • The largest Editas Medicine seller in Q3 2025 was Millennium Management, an estimated $4.3M sold.

Based on aggregated 13F filings for Q3 2025.